60289-67-0 Usage
Uses
Used in Pharmaceutical Synthesis:
1-Pyridin-3-ylpropan-1-amine is utilized as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new therapeutic agents. Its unique structure allows it to form part of complex molecular frameworks that can target specific biological pathways, thereby enhancing the efficacy of resulting drugs.
Used in Organic Compounds Synthesis:
In the field of organic chemistry, 1-Pyridin-3-ylpropan-1-amine is employed as an intermediate for the preparation of a variety of organic compounds. Its reactivity and structural features make it suitable for creating diverse chemical entities with potential applications in different industries.
Used in Research and Development Laboratories:
1-Pyridin-3-ylpropan-1-amine plays a significant role in research and development settings, where it is used in the preparation of various chemical substances. Its presence in laboratories underscores its importance in advancing scientific knowledge and facilitating the discovery of novel compounds with practical applications.
Overall, 1-Pyridin-3-ylpropan-1-amine's multifaceted applications across pharmaceuticals, organic chemistry, and research and development highlight its indispensable nature in the creation and understanding of new chemical entities and therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 60289-67-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,2,8 and 9 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 60289-67:
(7*6)+(6*0)+(5*2)+(4*8)+(3*9)+(2*6)+(1*7)=130
130 % 10 = 0
So 60289-67-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H12N2/c1-2-8(9)7-4-3-5-10-6-7/h3-6,8H,2,9H2,1H3
60289-67-0Relevant academic research and scientific papers
ORGANIC COMPOUNDS
-
Page/Page column 37, (2010/03/02)
The present invention relates to compounds of formula (I) wherein X, R1, R2, R3, R4 and R5 are as defined herein, which are useful for treating diseases which respond to CXCR2 receptor mediators. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
Anthranilamides and methods of their use
-
, (2008/06/13)
The present invention is related to anthranilamides of formula I, in which R(1) to R(7) have the meanings indicated herein, a process for their preparation, their use as medicaments, and pharmaceutical preparations containing them. The compounds act on the Kv1.5 potassium channel and inhibit a potassium current which is referred to as the ultra-rapidly activating delayed rectifier in the atrium of the human heart. The compounds are therefore suitable for use as novel antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias (e.g., atrial fibrillation (AF) or atrial flutter).
